IDiyas

For the Inventor, By the Inventor

Reinach, Switzerland

Evolva Sa


USPTO Granted Patents = 68



Trademarks = 6

Forward Citations = 417

Loading Chart...
Loading Chart...

211 inventors (with patents filed for the assignee):

goldMedal Jorgen Hansen (17 out of 20 patents)

silverMedal Jens Houghton-Larsen (15 out of 17 patents)

bronzeMedal Veronique Douchin (14 out of 15 patents)

4.  Michael Dalgaard Mikkelsen (13 out of 15 patents)

5.  Simon Carlsen (11 out of 12 patents)

6.  Kim Olsson (10 out of 10 patents)

7.  Ernesto Simon (10 out of 10 patents)

8.  Yaoquan Liu (9 out of 21 patents)

9.  Nina Nicoline Rasmussen (8 out of 9 patents)

10.  Michael Naesby (8 out of 9 patents)

11.  Michael Katz (7 out of 9 patents)

12.  Sathish Kumar (6 out of 7 patents)

13.  Muthuswamy Panchapagesa Murali (6 out of 6 patents)

14.  Esben Halkjaer Hansen (6 out of 13 patents)

15.  Jochen Förster (6 out of 13 patents)


Core Competencies:
Nootkatone
Steviol Glycosides
Mogroside Compounds
Biosynthesis
Rebaudioside D
Terpenes
Vanillin
Resveratrol
Sphingolipids
Arthropod Infestation
Microbial Fermentation
Phenylpropanoids

68 patents:

1. 11896008 - Use of nootkatone to treat mosquito infestations (2024-02-13),
2. 11821015 - Production of steviol glycosides in recombinant hosts (2023-11-21),
3. 11807888 - Production of steviol glycoside in recombinant hosts (2023-11-07),
4. 11800867 - Methods of repelling biting arthropods, reducing pathogen spread and treating arthropod infestation (2023-10-31),
5. 11737459 - Use of nootkatone to kill sap-sucking insects (2023-08-29),
6. 11530431 - Methods for improved production of Rebaudioside D and Rebaudioside M (2022-12-20),
7. 11466302 - Production of steviol glycosides in recombinant hosts (2022-10-11),
8. 11396669 - Production of steviol glycosides in recombinant hosts (2022-07-26),
9. 11248248 - Production of mogroside compounds in recombinant hosts (2022-02-15),
10. 11191266 - Methods and compositions for the treatment of infections and arthropod infestation (2021-12-07),
11. 11168343 - Production of steviol glycosides in recombinant hosts (2021-11-09),
12. 11155841 - Method for producing sphingoid base or sphingolipid (2021-10-26),
13. 11154057 - Use of nootkatone to treat mosquito infestations (2021-10-26),
14. 11136283 - Recovering and purifying resveratrol produced by microbial fermentation (2021-10-05),
15. 11111511 - Method for producing phytosphingosine or sphinganine (2021-09-07),
Evolva is a biotechnology company that focuses on developing and commercializing sustainable ingredients for various industries. They use advanced biotechnology to create high-value ingredients, including flavors, fragrances, and cosmetic ingredients, with a focus on sustainability and environmental impact reduction. Evolva partners with industry leaders, leveraging their technology platform to improve existing products or create new ingredients with better performance and sustainability. Through their innovative solutions, Evolva aims to contribute towards a more sustainable and healthier future.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

68 Patents

#5 in Reinach

#212 in Switzerland

#10,446 in the World

...
Reinach, Switzerland

Evolva Sa

Forward Citations = 417

211 inventors:

goldMedal Jorgen Hansen (17 out of 20 patents)

silverMedal Jens Houghton-Larsen (15 out of 17 patents)

bronzeMedal Veronique Douchin (14 out of 15 patents)

4.  Michael Dalgaard Mikkelsen (13 out of 15 patents)

5.  Simon Carlsen (11 out of 12 patents)

Please report any incorrect information to support@idiyas.com
Loading…